AKT1 and pancreatic neoplasm: Prior research has suggested in thyroid cancer, PLS3 triggers the Notch signaling pathway to promote malignant progression [29]; in pancreatic cancer, it enhances cancer cell proliferation through PI3K/AKT signaling [19].